Deleterious Germline BLM mutations and the risk for early-onset colorectal cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  De Voer, Richarda M ^a   Hahn, Marc Manuel ^a   Mensenkamp, Arjen R ^a   Hoischen, Alexander ^a   Gilissen, Christian ^a   Henkes, Arjen ^a   Spruijt, Liesbeth ^a   Van Zelst Stams, Wendy A ^a   Marleen Kets, C ^a   Verwiel, Eugene T ^a   Nagtegaal, Iris D ^a   Schackert, Hans K ^b   Van Kessel, Ad Geurts ^a   Hoogerbrugge, Nicoline ^a   Ligtenberg, Marjolijn J L ^a   Kuiper, Roland P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOM SYNDROME HELICASE; RECQ HELICASE;

ADULT; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; EXOME; FEMALE; GENE FREQUENCY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GERMLINE MUTATION; HEALTH SURVEY; HETEROZYGOSITY LOSS; HETEROZYGOTE; HIGH THROUGHPUT SEQUENCING; HUMAN; INFORMATION PROCESSING; MALE; MUTATION RATE; ONSET AGE; PEDIGREE; RISK;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DATASETS AS TOPIC; EXOME; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HETEROZYGOTE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MUTATION RATE; PEDIGREE; POPULATION SURVEILLANCE; RECQ HELICASES; RISK;

EID: 84941585711     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14060     Document Type: Article

References (22)

1. Berwick, M. et al. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res 67, 9591-9596 (2007).
2. Seemanova, E. et al. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst 99, 1875-1880 (2007).
3. Thompson, E. R. et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 8, e1002894 (2012).
4. Gruber, S. B. et al. BLM heterozygosity and the risk of colorectal cancer. Science 297, 2013 (2002).
5. Cleary, S. P. et al. Heterozygosity for the BLMAsh mutation and cancer risk. Cancer Res 3, 1769-1771 (2003).
6. Baris, H. N. et al. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome. Isr Med Assoc J 9, 847-850 (2007).
7. Balci, S. and Aktas, D. Mucinous carcinoma of the colon in a 16-year-old Turkish boy with Bloom syndrome: cytogenetic, histopathologic, TP53 gene and protein expression studies. Cancer Genet Cytogenet 111, 45-48 (1999).
8. ORoak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619-1622 (2012).
9. German, J., Sanz, M. M., Ciocci, S., Ye, T. Z. and Ellis, N. A. Syndrome-causing mutations of the BLM gene in persons in the Blooms Syndrome Registry. Hum Mutat 28, 743-753 (2007).
10. Exome Aggregation Consortium (ExAC), ExAC data set browser (2014). http://exac.broadinstitute.org (Date of access: 10/11/2014).
11. Payne, M. and Hickson, I. D. Genomic instability and cancer: lessons from analysis of Blooms syndrome. Biochem Soc Trans 37, 553-559 (2009).
12. Bernstein, K. A., Gangloff, S. and Rothstein, R. The RecQ DNA helicases in DNA repair. Annu Rev Genet 44, 393-417 (2010).
13. Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nature genetics 26, 424-429 (2000).
14. Goss, K. H. et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051-2053 (2002).
15. McDaniel, L. D. et al. Chromosome instability and tumor predisposition inversely correlate with BLM protein levels. DNA Repair 2, 1387-1404 (2003).
16. Suspitsin, E. N. et al. Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele. Med Oncol 31, 828 (2014).
17. DeRycke, M. S. et al. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev 22, 1239-1251 (2013).
18. Gylfe, A. E. et al. Eleven candidate susceptibility genes for common familial colorectal cancer. PLoS Genet 9, e1003876 (2013).
19. Smith, C. G. et al. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Hum Mutat 34, 1026-1034 (2013).
20. De Voer, R. M. et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology 145, 544-547 (2013).
21. Neveling, K. et al. A post-hoc comparison of the utility of Sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Human Mutat 34, 1721-1726 (2013).
22. Hiatt, J. B. et al. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res 23, 843-854 (2013).